IVF控制性卵巢刺激中卵丘细胞miRNome的年龄相关特征
本研究对53例接受医学辅助生殖女性成熟MII卵母细胞的卵丘细胞样本进行miRNA表达谱分析,发现母体年龄是卵丘细胞miRNA表达的独立影响因素,而促性腺激素治疗方案可能影响卵泡miRNA表达及IVF疗效。年轻患者miRNA浓度更高且数量更多,不同年龄组在r-hFSH+r-hLH与单用r-hFSH方案间存在37个miRNA的表达调控差异。
要点
- 母体年龄是卵丘细胞miRNA表达的独立影响因素。
- 促性腺激素治疗可能影响卵泡miRNA表达及IVF疗效。
- 年轻患者卵丘细胞miRNA浓度更高、数量更多,与治疗方案无关。
核心结论
- 母体年龄是卵丘细胞miRNA表达的独立影响因素。
- 促性腺激素治疗可能影响卵泡miRNA表达及IVF疗效。
- 卵丘细胞miRNA表达谱存在潜在的年龄和医学辅助生殖刺激依赖性特征。
研究设计与样本
- 研究纳入53例接受医学辅助生殖治疗女性成熟MII卵母细胞的53个卵丘细胞样本。
- 38个样本按母体年龄和促性腺激素方案合并为四个预设亚组:≥36岁+r-hFSH(n=10)、≥36岁+r-hFSH+r-hLH(n=10)、≤35岁+r-hFSH(n=9)、≤35岁+r-hFSH+r-hLH(n=9)。
- 使用PCR检测系统对752种人类miRNA进行表达谱分析,无需预扩增。
- 数据采用delta-delta Ct法进行相对定量和靶基因预测(至少四种算法预测同一miRNA-基因互作对HIT>4)。
主要发现
- 各亚组具有与年龄和医学辅助生殖刺激相关的独特miRNA表达谱。
- 37个miRNA簇在所有四个池中共同但差异表达。
- 在r-hFSH+r-hLH与单用r-hFSH方案比较中,年龄组(≤35岁或≥36岁)间37个miRNA的表达调控存在显著差异。
- 无论治疗方案如何,年轻患者中miRNA浓度更高且数量更多。
- 37个共同miRNA靶基因的高评分通路涉及MAPK信号通路、G alpha信号、转录调控、紧密连接、RNA聚合酶I和III及线粒体转录。
关键数值与推荐
- 功能注释富集分析使用miRSystem数据库,原始P值<0.05。
- 37个miRNA在所有四个池中共同但差异表达。
- 在r-hFSH+r-hLH与单用r-hFSH方案比较中,年龄组间37个miRNA表达调控存在显著差异。
- 年轻患者miRNA浓度和数量高于年长患者,与治疗方案无关。
临床怎么用
- 卵丘细胞miRNA表达受促性腺激素治疗调节并与年龄强相关。
- 深入理解miRNA表达模式与功能可能有助于开发治疗卵巢功能障碍和改善年长女性生育力的新疗法。
局限性
- 不能排除其他未知个体遗传或临床因素干扰所报告结果的可能性。
- miRNA谱分析使用预定义靶探针阵列,可能遗漏其他受年龄和激素刺激调节的miRNA分子。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is the microRNA (miRNA) expression pattern of cumulus oophorus cells (COCs) in women undergoing medically assisted reproduction (MAR) procedures differentially modulated according to patient age and gonadotropin treatment strategy? SUMMARY ANSWER: Maternal age is an independent factor impacting miRNA expression in COCs while gonadotropin treatment may affect follicular miRNA expression and IVF efficacy. WHAT IS KNOWN ALREADY: Epigenetic mechanisms in female infertility are complex and poorly studied. DNA methylation, histone modifications, miRNAs and nucleosome positioning influence cellular machinery through positive and negative feedback mechanisms either alone or interactively. miRNAs are important regulators during oogenesis, spermatogenesis and early embryogenesis, and are reported to play a role in regulating crosstalk between the oocyte and COCs. Although miRNome analysis has been performed in female human reproductive tissues (endometrium, myometrium, cervix and ovaries), epigenetic modifications in women with infertility have not been explored in detail. In addition, the impact of gonadotropin treatments during MAR on miRNA expression in COCs has not been fully investigated. STUDY DESIGN, SIZE, DURATION: This study was carried out in 53 COC samples obtained from mature metaphase II (MII) oocytes in 53 women undergoing MAR treatment. A total of 38 samples for assay development were pooled by maternal age and gonadotropin treatment into four predetermined subgroups: ≥36 years and recombinant human FSH (r-hFSH), n = 10; ≥36 years and r-hFSH+ recombinant human-luteinizing hormone (r-hLH), n = 10; ≤35 years and r-hFSH, n = 9; ≤35 years and r-hFSH+r-hLH, n = 9. miRNome profiles were determined and compared between subgroups. Expression of defined miRNAs was validated in the remaining fifteen samples, representative of each subgroup, by quantitative polymerase chain reaction (PCR). PARTICIPANTS/MATERIALS, SETTING, METHODS: COCs were processed for miRNA-enriched total RNA extraction and pooled in homogeneous subgroups to obtain a sufficient amount and quality of starting material to perform the analysis. Each pooled sample underwent miRNA profiling using PCR assay system to examine expression of 752 human miRNAs without pre-amplification. Data were analyzed using the delta-delta Ct method for relative quantitation and prediction of target genes (with at least four algorithms predicting the same miRNA-gene interaction pair (HIT)>4). The miRSystem database provided functional annotation enrichment (raw P-value <0.05) of co-expressed miRNAs. MAIN RESULTS AND THE ROLE OF CHANCE: We found distinctive miRNA expression profiles in each subgroup correlating with age and MAR stimulation. In addition, a number of selective and co-expressed miRNAs were revealed by comparative analysis. A cluster of 37 miRNAs were commonly but differentially expressed in all four pools. Significant differences were observed in expression regulation of 37 miRNAs between age groups (≤35 or ≥36) in women receiving r-hFSH+r-hLH compared to those receiving r-hFSH alone. Higher concentrations and increased numbers of miRNAs were recorded in younger than in older patients, regardless of treatment. Functional and expression studies performed to retrieve common miRNome profiles revealed an enrichment of biological functions in oocyte growth and maturation, embryo development, steroidogenesis, ovarian hyperstimulation, apoptosis and cell survival, glucagon and lipid metabolism, and cell trafficking. The highest scored pathways of target genes of the 37 common miRNAs were associated with mitogen-activated protein kinase (MAPK) signaling pathways, G alpha signaling, transcription regulation, tight junctions, RNA polymerase I and III, and mitochondrial transcription. We identified a potential age- and MAR stimulation-dependent signature in the miRNA landscape of COCs. LIMITATIONS, REASONS FOR CAUTION: We cannot rule out the possibility that other unknown individual genetic or clinical factors may have interfered with the reported results. Since miRNA profiling was conducted with a predefined array of target probes, other miRNA molecules, potentially modulated by age and hormonal stimulation, may have been missed in this study. WIDER IMPLICATIONS OF THE FINDINGS: miRNA expression in COCs is modulated by gonadotropin treatment and correlates strongly with age. A better understanding of the expression patterns and functions of miRNAs may lead to the development of novel therapeutics to treat ovarian dysfunction and improve fertility in older women. STUDY FUNDING/COMPETING INTEREST: This study was funded by Merck KGaA, Darmstadt, Germany. All authors declared no competing interest, except SL and TD who are fully employed by Merck KGaA. TRIAL REGISTRATION NUMBER: N/A.
引用
- Dell'Aversana C, Cuomo F, Longobardi S, et al. Age-related miRNome landscape of cumulus oophorus cells during controlled ovarian stimulation protocols in IVF cycles. Hum Reprod. 2021. PMID: 33454781. doi:10.1093/humrep/deaa364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。